newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results

●Q3 Revenue of $8.8 million ●Q3 Cash Collections of $10.0 million ●Q3 Thyroid test volume up 12% year-over-year to record levels ●Q3 Thyroid revenue of $8.8M; up 22% year-over-year to record levels PARSIPPANY, NJ,